‘So many relationships in the room’: Participant perspectives on the affordances and challenges of co‐therapy in psychedelic assisted therapy
Psychology and Psychotherapy: Theory, Research and Practice · 2026-12 · 99 (4) · 1604-1626
DOI: 10.1111/papt.70098 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Psychology and Psychotherapy: Theory, Research and Practice, online erschienen am 10.08.2026. Verfasst von Rachel Ham und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia. Hauptthemen laut MEDLINE: Hallucinogens, Psilocybin, Generalized Anxiety Disorder, Psychotherapy. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Usona Institute, Monash University, Incannex Healthcare Limited.
Abstract (Originalsprache)
Objectives
Psychedelic‐assisted therapy ( PAT ) frequently utilises a “cotherapy” model, in which two therapists jointly support participants throughout dosing and psychotherapy sessions. While common in clinical trials, participant experiences of cotherapy remain underexplored. This study explored cotherapy experiences in PAT with psilocybin for Generalised Anxiety Disorder ( GAD ).
Design
Longitudinal qualitative analysis of participants sampled from a large randomised, open‐label, phase 2 clinical trial of psilocybin‐assisted therapy for GAD , delivered by clinicians with high levels of qualification, training and supervision.
Methods
Qualitative data were collected from n = 18 participants via 29 semi‐structured interviews, conducted before and after dosing sessions. Interviews examined experiences of PAT with a cotherapy dyad. Data were analysed thematically, guided by Affordance Theory to consider how cotherapy dynamics shaped therapeutic possibilities.
Results
Three major themes were developed: (1) dose day cotherapy: safety, trust and the realities of access; (2) cotherapy influences therapeutic processes; and (3) cotherapy shapes the impact and credibility of therapeutic insights.
Conclusions
Cotherapy in PAT can be both a safety and supportive measure, and a potentiator of therapeutic processes. Insights from this study can guide clinical practice and future research to harness the potential safety and therapeutic benefits afforded by cotherapy while considering feasibility and accessibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
- School of Psychological Sciences, Monash University, Clayton, Victoria, Australia.
- School of Social Sciences, Monash University, Clayton, Victoria, Australia.
- Monash Bioethics Centre, School of Philosophical, Historical and Indigenous Studies, Monash University, Clayton, Victoria, Australia.
ORCID-Profile: Rachel Ham
Förderung
- Usona Institute
- Monash University
- Incannex Healthcare Limited
Zitieren
APA
Ham, R., Gardner, J., Carter, A., & Liknaitzky, P. (2026). ‘So many relationships in the room’: Participant perspectives on the affordances and challenges of co‐therapy in psychedelic assisted therapy. Psychology and Psychotherapy: Theory, Research and Practice, 99(4), 1604-1626. https://doi.org/10.1111/papt.70098
Vancouver
Ham R, Gardner J, Carter A, Liknaitzky P. ‘So many relationships in the room’: Participant perspectives on the affordances and challenges of co‐therapy in psychedelic assisted therapy. Psychology and Psychotherapy: Theory, Research and Practice. 2026;99(4):1604-1626. doi:10.1111/papt.70098
BibTeX
@article{Ham2026,
author = {Ham, Rachel and Gardner, John and Carter, Adrian and Liknaitzky, Paul},
title = {‘So many relationships in the room’: Participant perspectives on the affordances and challenges of co‐therapy in psychedelic assisted therapy},
journal = {Psychology and Psychotherapy: Theory, Research and Practice},
year = {2026},
volume = {99},
number = {4},
pages = {1604--1626},
doi = {10.1111/papt.70098}
}
EUVIMED